Recent estimates suggest that about 60% of the nation’s cats and dogs have obesity; hundreds of thousands of cats and dogs have diabetes. Better treatments are desperately needed, experts said.
Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback